Can Checkpoint Inhibition Be Used Therapeutically?
Yes, checkpoint inhibitors are being explored as therapeutic agents, particularly in cancer treatment. By targeting molecules like checkpoint kinases, these drugs can selectively kill cancer cells that rely on defective checkpoints to survive. However, this approach requires a nuanced understanding of the toxicological implications, as inhibiting checkpoints can also affect normal cells, leading to adverse effects.
